Sreelakshmi24’s Blog

where life is all about learning

Posts Tagged ‘expansion plans

Fortis announces aggressive plans for Clinique Darné now renamed ‘Fortis Clinique Darné’

leave a comment »

CIEL and Fortis Healthcare, who have recently announced a strategic tie up to pick up majority stake in Mauritius’ largest private hospital, Clinique Darné, today unveiled aggressive plans for the hospital. Fortis Healthcare, who have the operations and management contract for the hospital, have extensive plans to enhance the quality of healthcare services being provided. Dr. The Hon Navinchandra Ramgoolam, G.C.S.K. Prime Minister, Minister of Defense and Home Affairs graced the occasion and unveiled Fortis Clinique Darné‘s new logo. Mr. Shivinder Mohan Singh, Managing Director, Fortis Healthcare, Mr. Bhavdeep Singh, Chief Executive Officer, Fortis Healthcare and Mr. Gérald De Senneville, CIEL were present at the occasion.                   

Fortis Healthcare, India’s fastest growing healthcare delivery network plans to utilize its experience and expertise to upgrade and expand Fortis Clinic Darné in a two phased manner.

  • In phase I, the company will make an investment of MUR 66 million of a total of MUR 165 Mn invested and upgrade the current facility which will involve introduction of new specialties and upgradation of existing specialties to tertiary care level.
  • In Phase II, the company, utilizing the six acre land available, will expand the facility to become a 400-bedded super speciality hospital providing comprehensive medical services.

To support the upgradation of medical program, there will be introduction of a high end Critical Care Department. This will allow treatment of more complicated and high end cases. There will be introduction of high end Surgical ICU, Medical ICU and Pediatric ICU. Fortis also plans to introduce a Neonatal ICU which will be of tremendous support to the birthing program in the hospital. These Critical Care Units will meet an important need for people of Mauritius. Along with these, there will be extensive scaling up of Emergency Medicine and Ambulance Services. There will be introduction of comprehensive range of diagnostic services including high end Radiology & Laboratory services. While Clinique Darne was the first private player to introduce Cardiac Care in Mauritius, its Cardiac Program will receive significant strength and will be enhanced using the expertise of Fortis. Today Fortis runs the “Fortis Escorts Cardiac Program” which is one of the largest Cardiac Programs in the world.

Post the investment and creation of state of art super speciality healthcare hub, Mauritians would not be required to travel abroad for high end treatment and the hospital will also attract patients from neighbouring African countries. Fortis, known for its clinical excellence and compassionate patient care, will bring in its clinical and management expertise to further enhance the scope and the quality of services available at Fortis Clinique Darné.

According to Mr. Gérald De Senneville, CIEL, “Fortis is a renowned and highly respected name in the Indian healthcare space with significant contribution made to the sector. We are very proud of this association which has come up after considerable research. We are confident and optimistic that the experience and expertise that Fortis will bring to Fortis Clinique Darné will add immense value not only to the hospital but also to the Mauritian healthcare sector.”

Mr. Raj Gore, Chief Operating Officer of Fortis Clinique Darné further added that, “As a trusted health partner, Clinique Darné has always taken the leadership role to reinvent itself to provide the best of healthcare to the people of Mauritius. The association with an eminent group like Fortis is another milestone in the same tradition. We are very confident about adding real value to the clinical as well as hospital services. Our patients would undoubtedly be the first beneficiary of this.”

While commenting on his plans for Fortis Clinique Darné, Mr. Shivinder Mohan Singh said, “We are excited to be in Mauritius which has a strong cultural and historical connect with India. We are committed to bringing our healthcare expertise for betterment of healthcare standards not only in Fortis Clinique Darné but to the entire Mascaranes and beyond.”

Fortis follows Clinical Protocols found in the best Global Hospitals and has the honour of having a JCI accredited hospital and four hospitals having the coveted NABH accreditation issued by the Quality Council of India. Fortis will bring these protocols to Fortis Clinique Darné for significantly enhancing patient care.

Additionally, Fortis will introduce its’ Fortis Operating System (FOS), designed to provide uniform experience to patients across the Fortis network. FOS benchmarks the quality of services delivered at each patient interface point and creates systems and processes to deliver the same to provide the best in patient care.

Fortis will also continuously train and educate medical, paramedical, nursing and support services staff to ensure high quality service levels.

Cryo-Save aligns Business and step ups Growth Opportunities across Asia Pacific region

leave a comment »

Last week Cryo-Save Group, Europe’s largest stem cell company announced its plans to scale up its investments in its 100% subsidiary Cryo-Save India and Asia Pacific region to meet the emerging demands of these two high-growth markets. Cryo-Save Group will scale up its investment to 2 million Euros in the Asia Pac region with a 2 million earmarked for the India operations in the span of 36 months. Many developing countries have realised that stem cells which are present in umbilical cord blood at birth have immense potential to speed up treatments for life-threatening illnesses, injuries and disabilities – thereby opening new vistas of business opportunities for Cryo-Save Group. Increased investments to enhance sales and marketing operations along with focus on creating innovative propositions in select areas for Asia Pac customers form a part of Cryo-Save’s new business plan.

Stem cells are the natural repair kit of the human body. In the last 18 years more than 10000 patients have been treated with cord blood stem cells transplantations in over 150 countries. Umbilical cord blood stem cells have been used over the years in an increasing number of treatments including leukemia, myelodysplastic syndrome, red cell disorders and more. Currently stem cell research is being done for more than 85 diseases.

Rob Koremans,
Group CEO, Cryo-Save said, “Our new business alignment is a reflection of the significant role India plays in the company’s growth strategy. Cryo-Save is valued for its strong leadership presence in over 38 countries, cutting edge technology and fully automated storage facility that helps us to meet our customer’s needs. We have excellent long term relationships with our customers, including doctors and Government organizations across our European geographies. We are confident that our local marketing teams comprehend the diversity of Indian customers and continue to deliver sustained value“.

Speaking about the uniqueness of the Cryo-Save lab in India, Prof. Colin McGuckin, Scientific Director, Cryo-Save India said, “Our lab in Bangalore adheres to GMP & highest international standards. I was very impressed by it and we would be looking at Bangalore lab to do some of our projects”. Armed with 20 years of experience in stem cells, Professor McGuckin is an opinion leader who has been called upon by governments and hospitals around the world. He firmly believes that the stem cells which are present in umbilical cord blood at birth have immense potential to speed up treatments for life-threatening illnesses, injuries and disabilities.

Mr.V.R.Chandramouli, Managing Director, Cryo-Save India informed, “Women in India are slowly but steadily realizing the potential of banking their umbilical cord cells. It’s heartening to see this trend is omnipresent not only in metros but in other major cities of our country. Our endeavour like always has been to bring to the table a depth of expertise and experience in the stem cell banking space and we plan to devise new marketing strategies to reach out effectively to our target audience”.

Cryo-Save India is headquartered in Bangalore with a state-of-the art, one-of-its-kind, fully automated adult stem cell storage facility. The facility at Bangalore covers 10,000 sq ft with a storage capacity of 150,000 samples, expandable to 300,000 immediately. Cryo-Save India is the first company in India to offer dual storage, more than one time retrieval and confirms to global norms. The company will be offering collections and storage of ADULT stem cells derived from cord blood. The services will be available across all metros and other cities. The cost of the service is Rs. 75,000 which includes collection, processing and storing of the stem cells. The life span of the stem cells is 21 years. The payment is a onetime payment. Options of payment include a one year and six months duration instalment
schemes respectively.

Written by sreelakshmi

12 March, 2009 at 9:30 pm